pharma · PTIX
Protagenic Therapeutics, Inc.new
Protagenic Therapeutics is a pharma organization headquartered in NEW YORK, NY, USA. It trades on NYSE under ticker PTIX. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this enti
NEW YORK, NY, USA HQ
1 Employees
Public company Type
PTIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, USA
- Employees
- 1
- Programs
- 1
- Drugs
- 2
- Patents
- 0
PT00114-001A
Phase 1 · other · Phase I study in healthy male and female volunteers. Intended indication: mood disorders
PT00114-001A for Phase I study in healthy male and female volunteers. Intended indication: mood disorders is a Phase 1 program (other) at Protagenic Therapeutics, Inc.new with 1 ClinicalTrials.gov record(s).
Internal code PT00114-001A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Protagenic Therapeutics, Inc.new
- Phase
- Phase 1
- Modality
- other
- Indication
- Phase I study in healthy male and female volunteers. Intended indication: mood disorders
- Status
- active
- Trials
- 1